BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Five Collaborations Unlocking Faster Drug Development this Week

  This week, multiple companies have partnered in attempts to bring forth new therapies. BioSpace takes a look at some of these announcements.

  June 10, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Phase III Results Support BMS’ CAR-T Cell Therapy Breyanzi in Relapsed/Refractory B-Cell Lymphoma

  The new study findings may pave the way for Bristol Myers Squibb to receive additional approval for Breyanzi in a vulnerable patient population.

  June 10, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Business

  Three Biopharma Companies Close Series A Financing Rounds

  June appears to be a busy month for Series A financing rounds, with Kurome, Onchilles Pharma, and Hawthorne Effect closing in on millions of dollars worth of startup investments.

  June 10, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Drug Development

  Are Vindictive Variants Threatening Our COVID-19 Recovery?

  According to the CDC, the Delta variant now accounts for more than 6% of infections in the U.S. and may be responsible for 18% of cases in some Western states.

  June 10, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Business

  Biotech Whisperer John Edwards Seeks the Extraordinary at Verseau

  John Edwards, newly-appointed CEO of Verseau Therapeutics, is continually searching for something special.

  June 10, 2021

   · 

  5 min read

   · 

  Gail Dutton
• 

  Business

  Funding News: Synthekine, Bright Peak Each Raise $107 Million in Series B Rounds

  Synthekine and Bright Peak made announcements on their Series B rounds, while Hawthorne Effect and Owl Peak Labs also secured their funding. Let us take a look.

  June 10, 2021

   · 

  4 min read

   · 

  Alex Keown
• 

  Career Advice

  Biotech In-Demand Jobs: Remote Workers

  What are the benefits of becoming a remote worker? Let’s explore together.

  June 10, 2021

   · 

  4 min read

   · 

  Kymberlie Krieger
• 

  Drug Development

  Aducanumab Saga Continues as FDA Committee Members Resign Over Approval

  David S. Knopman and Joel S. Perlmutter both resigned from the committee after the approval of the drug aducanumab.

  June 10, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Lone Star Bio

  Research Roundup: A Cognitive Clock to Measure Brain Health and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  June 10, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Business

  BioSpace Movers & Shakers, June 11

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  June 10, 2021

   · 

  9 min read

   · 

  Alex Keown